Showing 1 - 5 results of 5 for search 'Federico Zazzetti', query time: 0.03s
Refine Results
-
1
LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population:... by Francisco Zevallos, Chetan S Karyekar, Federico Zazzetti, Jeniffer Lofland
Published 2022-07-01
Article -
2
-
3
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis... by Christopher T. Ritchlin, Atul Deodhar, Wolf‐Henning Boehncke, Enrique R. Soriano, Alexa P. Kollmeier, Xie L. Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S. Helliwell
Published 2023-03-01
Article -
4
611 Efficacy and safety of nipocalimab in adult patients with active systemic lupus erythematosus: design of a phase 2 study by Robert W Hoffman, Robert Gordon, Federico Zazzetti, Terence Rooney, Anne M Stevens, Jocelyn H Leu, Sheng Gao, Qing Zuraw, Fang Liu-Walsh, Bart van Hartingsveldt, Cesar Calderon, George Vratsanos
Published 2022-12-01Article -
5
LP-195 Design of a Phase 2 study evaluating the efficacy and safety of nipocalimab in adult patients with active systemic lupus erythematosus by Robert Hoffman, Robert Gordon, Federico Zazzetti, Terence Rooney, Jocelyn Leu, Anne Stevens, Sheng Gao, Qing Zuraw, Fang Liu-Walsh, Bart van Hartingsveldt, Cesar Calderon, George Vratsanos, YoungJa Lee
Published 2023-07-01Article